GliSODin Academy – 6 mini series about oxidative stress with Dr. Cory Goldberg In the videos, Dr. Goldberg explains what oxidative stress is, how it occurs, and the damage it can cause to the body. He also presents strategies for preventing and reducing oxidative stress, including eating a healthy diet, exercising regularly, and taking supplements.…
Oxidative stress and inflammation in aging process by Dr John Gaviria, MD Columbia The new e-learning series is available now : Oxidative stress and inflammation in aging process by Dr John Gaviria ISOCELL NUTRA is excited to offer this new e-learning series to healthcare professionals. The company believes that the series will help healthcare professionals…
GliSODin® abrogates asthma features and reduces CD4+ T-cell polarization and reactivation. Taken together, these data suggest that GliSODin® could be used for the management of asthma symptoms.
Clinical research and scientific evidence is presented to demonstrate that gliadin protects SOD during passage through the stomach, thus allowing absorption of the SOD enzyme once inside the intestine.
According to the results of this study, it was
concluded that supplementation with GliSODin can protect athletes from muscle damage and
decrease inflammation caused by intensive physical activity and have some positive influence on
the sports performance of elite rowers
The results showed that enteral administration of CME-gliadin of 1 IU/day and 5 IU/day
significantly increased SOD levels based on examination after 14 and 28 days. Also, it significantly decreased
MDA (p < 0.001), TNF-α (p < 0.001), and lactate levels in rats induced by sepsis
Melon GliSODin® tended to improve the subjective symptoms of participants who had knee or lower back pain or discomfort. Melon GliSODin® administration may help to prevent the progression of locomotive syndrome. Future studies involving larger sample sizes and more stringent randomization protocols are needed to determine differences between the placebo and Melon GliSODin® groups
We are very pleased to present you today with a new version of the GliSODin scientific platform.
After 24 weeks, a greater improvement in VES was observed in the GPSOD group (19.85%; SE 4.63, P < 0.0001) compared with the placebo group (8.83%; SE 4.72, P = 0.0676). Tolerance was good in both groups. No related side-effect was reported. Conclusions : The use of GP-SOD appears to be a useful add-on to phototherapy in the treatment of vitiligo patients
We are very pleased to present you today with a new version of the GliSODin scientific platform.
